The pharmaceutical group delisted from the stock exchange in 1999 and was bought out by Tiger Brands, which sought to take advantage of brands such as Panado, Bio-Plus and Corenza Para-C.
But Tiger saw the company mostly as a cash cow and failed to implement any significant capital investment, leaving it to trail behind competitors such as Aspen Pharmacare.
clipped from www.thetimes.co.za
No comments:
Post a Comment